BioGenerator Ventures
Venture capitalSt. Louis Β· Pre-SeedβSeries B Β· 1 people tracked
Investment thesis
BioGenerator Ventures provides catalytic investments to life sciences companies across human health and plant/agriculture sciences, including therapeutics, diagnostics, medical devices, research tools, and healthcare. It combines funding with the BioGenerator Labs engine of company-building resources β technology, talent, proof-of-concept grants, coaching, grant training, and laboratory space β to accelerate new ventures. The firm often supports companies from pre-company licensing and formation through early financing rounds, leading initial financings, orchestrating additional investors, and running diligence processes. It is closely tied to the St. Louis innovation ecosystem and frequently spins ventures out of local academic institutions.
Source: firm website, verified Aug 3, 2026.
Team Β· 1 people
from the firm's website
What they invest in
from 20 of 26 portfolio companiesBiotech Γ16Medical Devices Γ12Healthtech Γ10Deep Tech Γ7AI & Machine Learning Γ6AgTech Γ4Digital Health Γ3Cleantech Γ2
HQs:United StatesΓ15
Investments Β· 26 tracked
founders shown can be your intro pathPairidex develops a tumor-informed droplet digital PCR (ddPCR) fusion assay for detecting and monitoring blood cancer, aimed at cancer surveillance and therapeutic monitoring of gene fusion-driven disease.
BiotechHealthtechMedical DevicesSt. Louis, US
Allyson Mayer(Interim COO)Andrew Young(Founder & CSO)Paul Kortschak(CEO)Grant Challen(Co-Founder & Scientific Advisor)
BoardTodd Druley(Director)
Board seatCrystal WinkelerΒ· per SEC Form D
Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Bob Karr(Executive Chairman & CEO)
Benson Hill develops genetically optimized soy seed varieties using AI-driven plant science, targeting agricultural producers seeking more nutritious, sustainable, and energy-dense crop solutions.
AgTechAI & Machine LearningNew Materials
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples.
BiotechHealthtechMedical DevicesSaint Louis, US
EDWARD WEINSTEIN(President, Chief Executive Officer and Manager)CRYSTAL WINKELER(Chief Operating Officer)CHARLES BOLTEN(Director)DAVID KINGSLEY(Director)
BoardDAVID SMOLLER(Director)
Company supported through pre-company stage to growth
Cortex is a non-profit innovation district in St.
Enterprise SoftwareGovTechImpact & Social GoodSt. Louis, US
Valo Health applies technology and biotech expertise to advance drug discovery processes.
AI & Machine LearningBiotech
CoverCress Inc. develops agricultural products and seeds that enable farmers to convert idle winter fields into profitable crops.
AgTechCleantechClimate TechEnergy
Edison Agro Sciences develops bio-based synthetic rubber from sunflower crops as an alternative to petrochemical and natural rubber for industrial applications.
AgTechBiotechCleantechNew MaterialsSt. Louis, US
David Woodburn(Executive Officer, Director)Matthew B Crisp(Executive Officer, Director)Dan Broderick(Director)Thomas Hohn(Executive Officer, Director)Tom Christensen(Executive Officer, Director, Promoter)
BoardMatt Helms(Director)
Clinical diagnostics company demonstrating high sensitivity and specificity in pivotal trials
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Andrew Barnell(Chief Executive Officer & Co-founder)Erica Barnell(Co-founder)
Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy.
BiotechDeep TechDigital HealthMedical DevicesSt. Louis, US
Dr. Hode(Co-Founder & Senior Fellow)Mr. Alleruzzo(Co-Founder & Director)Dr. Chen(Co-Founder)Dr. Robert Nordquist(Co-Founder)David Smoller(Director)Charlie Bolten(Director)
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Nick Staten(Executive Officer)T. Scott Glover(Executive Officer)James D. Marselis(Director)Peter Reinecke(Director)Jonathan Sackier(Director)David Smoller(Director)
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement.
AI & Machine LearningBiotechHealthtechMedical DevicesSaint Louis, US
Richard Dorshow(Executive Officer, Director)Terence Stern(Executive Officer)Steven Hanley(Executive Officer, Director)Richard Lytle(Director)Charles Bolten(Director)John A. Friel(Director)
Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Dr. Harding(Primary Founder)Mario Feldman(Founder, Scientific Founder)Viliam PavliakBenjamin Moutier
BoardDr. SzymanskiDr. Projan
Panome Bio provides multi-omics discovery services using mass spectrometry-based metabolomics and proteomics to identify biomarkers and generate mechanistic insights for research institutions and pharmaceutical companies.
AI & Machine LearningBiotechDeep Tech<UNKNOWN>, US
David Smoller(Director)Deval Lashkari(Director)Alexander Herzick(Director)Edward Weinstein(Executive Officer, Director)Tom Cohen(Executive Officer)Rob Capone(Director)
Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods.
AgTechBiotechSt. Louis, US
Jeffrey Staub(Executive Officer, Director)Charles Bolten(Director)Dave Duncan(Director)Elizabeth Gallegos(Executive Officer)Brian Clevinger(Director)
BoardMartha Schlicher(Executive Officer, Director)
SentiAR builds CommandEP, an FDA-cleared mixed-reality holographic augmented reality platform for cardiac electrophysiology that converts real-time catheter data into hands-free 3D holograms and virtual screens for electrophysiologists during procedures.
AI & Machine LearningHealthtechMedical DevicesSt. Louis, US
Sean Churchill(Director)Warren Watson(Director)Jonathan Silva(Executive Officer, Director)Berk Tas(Executive Officer, Director)James Patrick Howard(Executive Officer)CMO & Co-Founder (Professor of Pediatrics & Biomedical Engineering, Washington University in St. Louis)(CMO & Co-Founder)
Allotera (formerly Wugen) develops allogeneic T-cell therapies.
BiotechHealthtechMedical DevicesSt. Louis, US
Ayman Kabakibi(Executive Officer)Drew Dennison(Director)Niall O'Donnell(Director)Bosun Hau(Director)Kevin Li(Director)Peter Kiener(Director)
Frequently asked questions
- What stage does BioGenerator Ventures invest at?
- BioGenerator Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is BioGenerator Ventures's typical check size?
- BioGenerator Ventures typically writes checks of $50K β $250K.
- What sectors does BioGenerator Ventures focus on?
- BioGenerator Ventures focuses on AgTech, Biotech, Digital Health, FoodTech, Healthtech, Medical Devices.
- Where is BioGenerator Ventures located?
- BioGenerator Ventures is headquartered in St. Louis, US.
- Does BioGenerator Ventures lead rounds?
- Yes, BioGenerator Ventures leads investment rounds.
Images
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
VTC Ventures is an early-stage venture fund managed by Middleland Capital and backed by strategic LPs including Virginia Tech, the Fralin Biomedical Research Institute, and Carilion Clinic. It invests in healthcare, deep tech/defense/AI, and food & agriculture, offering founders access to clinical, research, and commercialization resources.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.